← back to search

Peter G. Shields

Georgetown University Medical Center · US
Area of research
Molecular Biology · Physiology
Research interest
Research interests include Smoking Behavior and Cessation, Carcinogens and Genotoxicity Assessment, Epigenetics and DNA Methylation, and Cancer Risks and Factors.
h-index
80
citations
23,248
works
569
NIH funding
primary concept
Medicine
email

Recent publications

Depression and Inflammation Predict Depression Trajectory of Non-Small Cell Lung Cancer Patients.
2025cited by 0position: contributordoi
Sex-specific lung inflammation and mitochondrial damage in a model of electronic cigarette exposure in asthma.
2023cited by 15position: contributordoi
Untargeted Metabolomics and Body Mass in Adolescents: A Cross-Sectional and Longitudinal Analysis.
2023cited by 6position: contributordoi
A Pilot Cross-Sectional Study of Immunological and Microbiome Profiling Reveals Distinct Inflammatory Profiles for Smokers, Electronic Cigarette Users, and Never-Smokers.
2023cited by 5position: contributordoi
Selective suppression of de novo SARS-CoV-2 vaccine antibody responses in patients with cancer on B cell–targeted therapy
JCI Insight 2023cited by 3position: contributordoi
Role of untargeted omics biomarkers of exposure and effect for tobacco research.
2023cited by 1position: contributordoi
Data from Saliva and Lung Microbiome Associations with Electronic Cigarette Use and Smoking
2023cited by 0position: contributordoi
Supplementary Figure from Saliva and Lung Microbiome Associations with Electronic Cigarette Use and Smoking
2023cited by 0position: contributordoi
Supplementary Table from Saliva and Lung Microbiome Associations with Electronic Cigarette Use and Smoking
2023cited by 0position: contributordoi
Supplementary Table from Saliva and Lung Microbiome Associations with Electronic Cigarette Use and Smoking
2023cited by 0position: contributordoi
Data from Saliva and Lung Microbiome Associations with Electronic Cigarette Use and Smoking
2023cited by 0position: contributordoi
Supplementary Figure from Saliva and Lung Microbiome Associations with Electronic Cigarette Use and Smoking
2023cited by 0position: contributordoi
Illness perception profiles and psychological and physical symptoms in newly diagnosed advanced non-small cell lung cancer.
2022cited by 30position: contributordoi
Saliva and Lung Microbiome Associations with Electronic Cigarette Use and Smoking.
2022cited by 22position: contributordoi
Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
2021cited by 48position: contributordoi
E-Cigarette or Vaping Product Use–associated Lung Injury: Developing a Research Agenda. An NIH Workshop Report
American Journal of Respiratory and Critical Care Medicine 2020cited by 60position: middledoi
Effects of cessation of cigarette smoking on eicosanoid biomarkers of inflammation and oxidative damage.
2019cited by 19position: contributordoi
Cigarette Filter Ventilation and its Relationship to Increasing Rates of Lung Adenocarcinoma
JNCI Journal of the National Cancer Institute 2017cited by 133position: lastdoi
Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia
Blood 2014cited by 68position: middledoi
Adipokines in Plasma and Breast Tissues: Associations with Breast Cancer Risk Factors
Cancer Epidemiology Biomarkers & Prevention 2012cited by 37position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

· 15 papers (2019–2025)Min-Ae Song · The Ohio State University9 papers (2022–2023)Jo L Freudenheim · University of Puerto Rico System9 papers (2022–2023)Mark D. Wewers · National Institutes of Health8 papers (2022–2023)Joseph Paul McElroy · The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute8 papers (2022–2023)Noah Whiteman · The Ohio State University8 papers (2022–2023)Ewy Mathé · The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute8 papers (2022–2023)Kevin L. Ying · The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute8 papers (2022–2023) · 4 papers (2019–2025) · 2 papers (2022–2025)Theodore M. Brasky · The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute2 papers (2017–2023)Barbara L. Andersen · Aarhus University2 papers (2022–2025)Cătălin Marian · New York University2 papers (2012–2017)Neal L. Benowitz · Lawrence Berkeley National Laboratory1 papers (2017–2017)Maciej Ł. Goniewicz · Roswell Park Comprehensive Cancer Center1 papers (2020–2020)Rafael J. Convit · New York University1 papers (2012–2012)William G. Wierda · The University of Texas MD Anderson Cancer Center1 papers (2014–2014)David Lucas · Vital Strategies1 papers (2014–2014)Carol Farver · Case Western Reserve University1 papers (2020–2020)Amy S. Ruppert · The University of Texas MD Anderson Cancer Center1 papers (2014–2014)